Inflection Biosciences & RCSI enter research collaboration to target Therapy Resistant BC treatment.
Dublin, Ireland, November 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and...
top of page
News
Press Releases
Nov 2, 2017
Inflection Biosciences to Present at Investor Conferences in November 2017
Dublin, Ireland, November 2, 2017 Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Jun 22, 2017
Inflection Biosciences Announces Pre-clinical Data to be Presented at 2nd EACR-AACR-SIC Special Conf
Dublin, Ireland, June 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
May 14, 2017
Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2017
Dublin, Ireland, May 15th, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Jan 4, 2017
Inflection Biosciences to Present at Biotech Showcase 2017
Dublin, Ireland, January 4, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
bottom of page